Abstract. The direct involvment of the Wilm's tumor suppressor gene (WT1) in Denys-Drash syndrome through mutations within exons 8 or 9 has recently been established. The absence of such alterations in three patients with Frasier syndrome provides a molecular basis for distinguishing these two syndromes that are associated with streak gonads, pseudohermaphroditism and renal failure.
Introduction
The association of chronic renal failure with XY gonadal dysgenesis is well known (Drash et al. 1970; Frasier et al. 1964) . However, some patients do not develop renal Wilm's tumor, but have an increased likehood of developing gonadoblastoma. These patients have been grouped under the generic term "Frasier'syndrome" by Moorthy et al. (1987) . The recent discovery of the presence of point mutations in the newly described Wilm's tumor suppressor gene WT1 in 10 independent cases of Denys-Drash syndrome (Pelletier et al. 1991 ) has led us to search for such mutations in Frasier syndrome. We report here a sequence comparison between an individual with DenysDrash syndrome and three patients with Frasier syndrome, with respect to WT1 exons 8 and 9.
Materials and methods
The three Frasier patients (Che, Del and Mar) suffered nephrotic syndrome with important proteinuria. They all underwent renal transplantation. Their chromosome analysis revealed 46-XY with gonadal dysgenesis. Their gonads were streak gonads and, for Che, one of them was tumoral. A bilateral castration was carried out in each case.
The Denys-Drash patient (A 1 ) had a female phenotype with XY gonadal dysgenesis and severe renal failure. Laboratory investigations confirmed the nephrotic syndrome with diffuse mesanglial sclerosis and a unilateral Wilm's tumor was discovered.
Correspondence to: P. Berta Polymerase chain reaction (PCR) amplifications of the TW1 exons 8 or 9 were carried out using the primer sets W8A:5"-ACA GCT GCC AGC AAT GAG AA-3", W8S: 5"-GAG ATC CCC AAA AGG AGT ATC A-3", and W9A: 5"CTT TTC CAA TCC CTC TCA TCA-3", W9S: 5"-CAT TGT TAG GGC CGA GGC TA-3", respectively. Primers were designed with respect to the genomic WTI sequence described in Gessler et al. (1992) .
A 176-bp PCR product for exon 8 and a 218-bp PCR product for exon 9 were obtained after 35 cycles of 30 s at 94 ~ C, 30 s at 60 ~ C, and I min at 72~ PCR products were purified by centrifugation through Spin Bind DNA extraction units (FMC). One tenth of the reaction mixture was used for dideoxy-sequencing using a sequenase kit (U.S. Biochemical) with 10gmoles of the same oligonucleotides as primers according to the method of Casanova et al. (1990) .
Single-strand chain polymorphism (SSCP) analysis were performed as described previously (Orita et al. 1989) , and the non-denaturating gels run under two standard conditions, either at 4~ or at room temperature, with 10% glycerol. Primer sequences were: wt-ls, 5"-GGGCGTCCGGGTCTGAGCCT-3", and wt-la, 5"-CCGGAAAAGTGGACAGTGAAGGCG-3" for exon 1; wtl2s, 5"-CGAGGAGCAGTGCCTGAG-3", and wtl-2a 5"-GCGGA-GAGTCCCTGGCGC-3", and wt-2s, 5"-CGAGAGCACCGC-TGACACTG-3", and wt-2a, 5"-GAGAAGGACTCCACTTGG-TTCCG-3" for exon 2; wt-3s, 5"-CCAGGCTCAGGATCTCGT-GT-3", and wt-3a, 5"-AAGGACCCAGACGCAGAGC-3" for exon 3; wt-4s, 5"-TGCTTTTGAAGAAACAGTTGTG-3", and wt-4a, 5"-GGAAAGGCAATGGAATAGAGA-3" for exon 4; wt-5s, 5"-GGGCTTTTCACTGGATTCTG-3", and wt-5a, 5"-CCATTT-GCTTTGCCATCTCC-3" for exon 5; wt-6s, 5"-GTGAGCCA-CACTGAGCCTTT-3" and wt-6a, 5"-GGCCGGTAAGTAGGAA-GAGG-3" for exon 6; wt-7s, 5"-GGCTTAAAGCCTCCCTTCCT-3", and wt-7a, 5 "-TGAGAGCCTGGAAAAGGAGC-3" for exon 7; wt-8s, 5"-GAGATCCCCTTTI'CCAGTATCA-3", and wt-8a, 5"-ACAGCTGCCAGCAATGAGAA-3" for exon 8; wt-9s, 5"-CAT-TGTTAGGGCCGAGGCTA-3", and wt-9a, 5"-CTTTTCCAA-TCCCTCTCATCA-3" for exon 9; wt-10s, 5"-TGTGCCTGT-CTCTTTGTTGC-3" and wt-10a, 5"-GTTCACACACTGTGC-TGCCT-3" for exon 10.
Results and discussion
The four patients were analyzed to determine the presence or absence of point mutations in WT1 exons 8 or 9. Genomic DNAs isolated from peripheral blood lymphocytes were subjected to direct sequencing after amplification with the appropriate primers. No mutation could be found in exon 8 in each case (data not shown). The individual with Denys-Drash syndrome displayed the same hemizygous mutation in exon 9 (Fig. 1) as the majority of patients analyzed in Pelletier et al. (1991) . This C to T transition converts 394Arg to Trp within the third zinc finger domain of WT1 and thus potentially affects the DNA-binding properties of the resulting transcription factor. On the other hand, D N A from all the patients with Frasier syndrome showed no mutations in exon 9. However, the presence of W T I abnormalities in Frasier syndrome cannot be excluded elsewhere in the gene, although it appears unlikely because of the absence of W i l m ' s tumor development. The D N A s of the three patients were tested using SSCP assay for alterations in the coding region of exons 1-10 of WT1 with the exception of the 5" half of exon 1 that is so GC-rich that it cannot be amplified reproducibly in our hands. In all reactions, there was no difference of the banding patterns compared with that seen in several control samples. An example of such an SSCP analysis is provided in Fig. 2 . However, the S S C P method may fail to detect some point mutations and has been described with an estimated 80% of point mutations being detectable (Orita et al. 1990 ). Furthermore, large deletions in the sex-determining region of the Y chrom o s o m e of such individuals or mutations localized in the sex-determining gene SRY have not been detected (Berta et al. 1992) . Thus, the molecular origin of this syndrome affecting urogenital development remains an open question.
In conclusion, although the Frasier and Denys-Drash syndromes sometimes appear to be difficult to distinguish clinically, our results provide a possible molecular basis for separating these two syndromes on a genetic basis.
